TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Occupational Therapy in Parkinson's Disease: a Randomized Controlled Trial
Brief Summary: The purpose of this study is to determine the effectiveness of occupational therapy in Parkinson's disease.


Options:
A: Arm Label: occupational therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Occupational Therapy | Arm Label: No occupational therapy; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Occupational Therapy; Assigned to Arm(s): occupational therapy
B: Arm Label: Early Pramipexole; Type: EXPERIMENTAL; Interventions: Drug: pramipexole | Arm Label: Delayed Pramipexole; Type: EXPERIMENTAL; Interventions: Drug: pramipexole | Intervention Type: DRUG; Name: pramipexole; Assigned to Arm(s): Delayed Pramipexole, Early Pramipexole
C: Arm Label: 1mg rasagiline; Type: EXPERIMENTAL; Interventions: Drug: Rasagiline Mesylate | Arm Label: 2mg rasagiline; Type: EXPERIMENTAL; Interventions: Drug: Rasagiline Mesylate | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Rasagiline Mesylate; Assigned to Arm(s): 1mg rasagiline | Intervention Type: DRUG; Name: Rasagiline Mesylate; Assigned to Arm(s): 2mg rasagiline | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: pardoprunox | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Pardoprunox | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Drug: Pardoprunox | Arm Label: 4; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: pardoprunox; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Pardoprunox; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Pardoprunox; Assigned to Arm(s): 3 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 4

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase II Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Brief Summary: This Phase II study is a randomized, double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of rhuMAb Beta7 in patients with moderate to severe ulcerative colitis.


Options:
A: Arm Label: Dex 21-P; Type: EXPERIMENTAL; Interventions: Drug: Dex 21-P | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Dex 21-P; Assigned to Arm(s): Dex 21-P | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: visilizumab | Arm Label: visilizumab; Type: EXPERIMENTAL; Interventions: Drug: visilizumab | Intervention Type: DRUG; Name: visilizumab; Assigned to Arm(s): visilizumab | Intervention Type: DRUG; Name: visilizumab; Assigned to Arm(s): placebo
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Granulated mesalamine | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Granulated mesalamine; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
D: Arm Label: rhuMAb Beta7; Type: EXPERIMENTAL; Interventions: Drug: rhuMAb Beta7 | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo | Intervention Type: DRUG; Name: rhuMAb Beta7; Assigned to Arm(s): rhuMAb Beta7

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase II Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Brief Summary: This Phase II study is a randomized, double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of rhuMAb Beta7 in patients with moderate to severe ulcerative colitis.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Arm Label: Golimumab 100 mg -> 50 mg; Type: EXPERIMENTAL; Interventions: Biological: Golimumab 100 mg, Biological: Golimumab 50 mg | Arm Label: Golimumab 200 mg -> 100 mg; Type: EXPERIMENTAL; Interventions: Biological: Golimumab 100 mg, Biological: Golimumab 200 mg | Arm Label: Golimumab 400 mg -> 200 mg; Type: EXPERIMENTAL; Interventions: Biological: Golimumab 200 mg, Biological: Golimumab 400 mg | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: BIOLOGICAL; Name: Golimumab 100 mg; Assigned to Arm(s): Golimumab 100 mg -> 50 mg, Golimumab 200 mg -> 100 mg | Intervention Type: BIOLOGICAL; Name: Golimumab 200 mg; Assigned to Arm(s): Golimumab 200 mg -> 100 mg, Golimumab 400 mg -> 200 mg | Intervention Type: BIOLOGICAL; Name: Golimumab 400 mg; Assigned to Arm(s): Golimumab 400 mg -> 200 mg | Intervention Type: BIOLOGICAL; Name: Golimumab 50 mg; Assigned to Arm(s): Golimumab 100 mg -> 50 mg
B: Arm Label: Vedolizumab; Type: EXPERIMENTAL; Interventions: Drug: vedolizumab | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: vedolizumab; Assigned to Arm(s): Vedolizumab | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: rhuMAb Beta7; Type: EXPERIMENTAL; Interventions: Drug: rhuMAb Beta7 | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo | Intervention Type: DRUG; Name: rhuMAb Beta7; Assigned to Arm(s): rhuMAb Beta7
D: Arm Label: Adalimumab 80/40; Type: EXPERIMENTAL; Interventions: Biological: adalimumab | Arm Label: Adalimumab 160/80/40; Type: EXPERIMENTAL; Interventions: Biological: adalimumab | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: placebo | Intervention Type: BIOLOGICAL; Name: adalimumab; Assigned to Arm(s): Adalimumab 80/40 | Intervention Type: BIOLOGICAL; Name: adalimumab; Assigned to Arm(s): Adalimumab 160/80/40 | Intervention Type: BIOLOGICAL; Name: placebo; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Multi-Center Medication Reconciliation Quality Improvement Study
Brief Summary: Patients often have problems after they leave the hospital, in part because errors are made in the medications they are prescribed. The goal of this project is to develop a more accurate and safe medication prescription process when patients enter and leave the hospital and implement this process at six U.S. hospitals. The investigators will measure the success of the project and develop lessons learned so this process can be applied to other hospitals.


Options:
A: Arm Label: I; Type: EXPERIMENTAL; Interventions: Other: Drug review 80+ -To reduce usage of hospital care | Arm Label: C; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Drug review 80+ -To reduce usage of hospital care; Assigned to Arm(s): I
B: Arm Label: Pre-intervention; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Mentored medication reconciliation quality improvement | Intervention Type: OTHER; Name: Mentored medication reconciliation quality improvement; Assigned to Arm(s): Intervention
C: Intervention Type: BEHAVIORAL; Name: Integration of a team based clinical pharmacist; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Optimizing therapeutic treatments; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Optimizing processes of care; Assigned to Arm(s): N/A
D: Arm Label: Unrestricted; Type: ACTIVE_COMPARATOR; Interventions: Other: Unrestricted | Arm Label: Restricted; Type: ACTIVE_COMPARATOR; Interventions: Other: Restricted | Intervention Type: OTHER; Name: Unrestricted; Assigned to Arm(s): Unrestricted | Intervention Type: OTHER; Name: Restricted; Assigned to Arm(s): Restricted

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Empowering Daughters and Mother-in-laws to Mitigate Gender-based Violence and Promote Women's Health in India
Brief Summary: A growing body of research indicates that gender-based violence (GBV) is a major global public health challenge. Yet, there is a dearth of evidence to guide program planning and policy-making efforts to reduce GBV. Our study will evaluate the feasibility, safety, and potential effectiveness of an innovative women's empowerment intervention to reduce GBV and related adverse health outcomes. It is expected that the study findings will provide evidence to determine if a phase 3 effectiveness trial is merited and advance the science underlying GBV prevention.


Options:
A: Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: RHANI Wives Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: RHANI WIves | Intervention Type: BEHAVIORAL; Name: RHANI WIves; Assigned to Arm(s): RHANI Wives Intervention
B: Arm Label: advocacy intervention; Type: EXPERIMENTAL; Interventions: Behavioral: advocacy intervention | Arm Label: Usual community services; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: usual community services | Intervention Type: BEHAVIORAL; Name: advocacy intervention; Assigned to Arm(s): advocacy intervention | Intervention Type: BEHAVIORAL; Name: usual community services; Assigned to Arm(s): Usual community services
C: Arm Label: Intervention arm; Type: EXPERIMENTAL; Interventions: Behavioral: The SHARE Project | Arm Label: Control arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: The SHARE Project; Assigned to Arm(s): Intervention arm
D: Arm Label: Primary Care for DILs; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Primary care for Daughters-in-Law | Arm Label: Standard Care plus Dil Mil Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: The Dil Mil Intervention | Intervention Type: BEHAVIORAL; Name: Primary care for Daughters-in-Law; Assigned to Arm(s): Primary Care for DILs | Intervention Type: BEHAVIORAL; Name: The Dil Mil Intervention; Assigned to Arm(s): Standard Care plus Dil Mil Intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Empowering Daughters and Mother-in-laws to Mitigate Gender-based Violence and Promote Women's Health in India
Brief Summary: A growing body of research indicates that gender-based violence (GBV) is a major global public health challenge. Yet, there is a dearth of evidence to guide program planning and policy-making efforts to reduce GBV. Our study will evaluate the feasibility, safety, and potential effectiveness of an innovative women's empowerment intervention to reduce GBV and related adverse health outcomes. It is expected that the study findings will provide evidence to determine if a phase 3 effectiveness trial is merited and advance the science underlying GBV prevention.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Public Health Nurse Home Visit | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Intimate Partner Violence (IPV) Protocol | Intervention Type: BEHAVIORAL; Name: Public Health Nurse Home Visit; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Intimate Partner Violence (IPV) Protocol; Assigned to Arm(s): 2
B: Arm Label: Primary Care for DILs; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Primary care for Daughters-in-Law | Arm Label: Standard Care plus Dil Mil Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: The Dil Mil Intervention | Intervention Type: BEHAVIORAL; Name: Primary care for Daughters-in-Law; Assigned to Arm(s): Primary Care for DILs | Intervention Type: BEHAVIORAL; Name: The Dil Mil Intervention; Assigned to Arm(s): Standard Care plus Dil Mil Intervention
C: Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): N/A
D: Intervention Type: BEHAVIORAL; Name: Home Visiting; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Salbutamol: Tolerance to Bronchoprotection vs. Methacholine: Time Course of Onset
Brief Summary: Overuse of inhaled bronchodilator beta agonist medication results in a loss of effectiveness (i.e. tolerance). This has been shown for the short acting beta agonist salbutamol and the long acting beta agonist salmeterol. Tolerance to salmeterol is present within 24 hours. The onset of tolerance to salbutamol is not known.


Options:
A: Arm Label: Montelukast 7 mg; Type: EXPERIMENTAL; Interventions: Drug: montelukast sodium | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: montelukast sodium; Assigned to Arm(s): Montelukast 7 mg | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo
B: Arm Label: salbutamol; Type: ACTIVE_COMPARATOR; Interventions: Drug: salbutamol | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: salbutamol; Assigned to Arm(s): salbutamol | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): placebo
C: Arm Label: A1; Type: ACTIVE_COMPARATOR; Interventions: Drug: montelukast | Arm Label: A2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: montelukast; Assigned to Arm(s): A1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): A2
D: Intervention Type: DEVICE; Name: Integrated Care Pathway; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Organization Program of DiabEtes INsulIN ManaGement: An Open, Multi-center, Prospective, Randomized, 16-week, Controlled Clinical Study
Brief Summary: Diabetes is a common, costly condition associated with significant morbidity and mortality. Diabetes self-management education, the process of teaching individuals to manage their diabetes, has been considered an important part. The intensive education has the capacity to deliver effective interventions to a large number of people. The investigators may be able to redirect our efforts to diabetes care and education strategies that will have a positive impact on the optimization of glycemic control and the prevention of long-term complications of diabetes, reducing the subsequent human and health care costs.


Options:
A: Intervention Type: BEHAVIORAL; Name: Customized Physician Intervention; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Customized Patient Intervention; Assigned to Arm(s): N/A
B: Arm Label: Structured Education Group; Type: EXPERIMENTAL; Interventions: Behavioral: Structured Education, Drug: Scilin®M30 | Arm Label: Conventional Care Group:; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Conventional Diabetes Education, Drug: Scilin®M30 | Intervention Type: BEHAVIORAL; Name: Structured Education; Assigned to Arm(s): Structured Education Group | Intervention Type: BEHAVIORAL; Name: Conventional Diabetes Education; Assigned to Arm(s): Conventional Care Group: | Intervention Type: DRUG; Name: Scilin®M30; Assigned to Arm(s): Conventional Care Group:, Structured Education Group
C: Intervention Type: BEHAVIORAL; Name: Nurse Case Manager and Community Health Worker Team; Assigned to Arm(s): N/A
D: Arm Label: Training course for practice nurses in autonomy support; Type: EXPERIMENTAL; Interventions: Behavioral: Training course for practice nurses in autonomy support | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Training course for practice nurses in autonomy support; Assigned to Arm(s): Training course for practice nurses in autonomy support

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Breastfeeding Education and Support Trial for Obese Women (BESTOW)
Brief Summary: The primary objective of this study is to evaluate the efficacy of a specialized exclusive breastfeeding education and support program targeting obese, pregnant, low-income women in Hartford, CT. Specifically, the investigators will evaluate the impact of the intervention on exclusive and partial breastfeeding rates at birth, 1, 3 and 6 months pp. Secondary aims of this study are: a) to characterize postpartum weight loss patterns and blood pressure values of obese women, by study group; and b) to evaluate potential differences in infant morbidity (diarrhea, otitis media and rehospitalization), by study group.


Options:
A: Arm Label: Community behaviour change campaign; Type: EXPERIMENTAL; Interventions: Behavioral: Community behaviour change campaign | Arm Label: No community behaviour change campaign; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Community behaviour change campaign; Assigned to Arm(s): Community behaviour change campaign
B: Arm Label: BFHI steps 1-9; Type: EXPERIMENTAL; Interventions: Other: implementation of the Baby-Friendly Hospital Initiative | Arm Label: BFHI steps 1-9 +well-child clinic; Type: EXPERIMENTAL; Interventions: Other: BFHI steps 1-9 +well-child clinic | Arm Label: usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: implementation of the Baby-Friendly Hospital Initiative; Assigned to Arm(s): BFHI steps 1-9 | Intervention Type: OTHER; Name: BFHI steps 1-9 +well-child clinic; Assigned to Arm(s): BFHI steps 1-9 +well-child clinic
C: Arm Label: Breastfeeding Peer Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Breastfeeding Peer Counseling | Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Breastfeeding Peer Counseling; Assigned to Arm(s): Breastfeeding Peer Counseling
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Intervention; Assigned to Arm(s): Intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Breastfeeding Education and Support Trial for Obese Women (BESTOW)
Brief Summary: The primary objective of this study is to evaluate the efficacy of a specialized exclusive breastfeeding education and support program targeting obese, pregnant, low-income women in Hartford, CT. Specifically, the investigators will evaluate the impact of the intervention on exclusive and partial breastfeeding rates at birth, 1, 3 and 6 months pp. Secondary aims of this study are: a) to characterize postpartum weight loss patterns and blood pressure values of obese women, by study group; and b) to evaluate potential differences in infant morbidity (diarrhea, otitis media and rehospitalization), by study group.


Options:
A: Arm Label: Lifestyle Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Balance after Baby Lifestyle Intervention Program | Arm Label: Post-gestational diabetes mellitus (GDM) Follow-up Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Balance after Baby Lifestyle Intervention Program; Assigned to Arm(s): Lifestyle Intervention group
B: Arm Label: Breastfeeding Peer Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Breastfeeding Peer Counseling | Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Breastfeeding Peer Counseling; Assigned to Arm(s): Breastfeeding Peer Counseling
C: Arm Label: Education Home Visits; Type: EXPERIMENTAL; Interventions: Other: Education Home Visits | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Education Home Visits; Assigned to Arm(s): Education Home Visits
D: Arm Label: Lifestyle counseling; Type: EXPERIMENTAL; Interventions: Behavioral: moderate exercise and healthy, low-fat diet | Intervention Type: BEHAVIORAL; Name: moderate exercise and healthy, low-fat diet; Assigned to Arm(s): Lifestyle counseling

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Breastfeeding Education and Support Trial for Obese Women (BESTOW)
Brief Summary: The primary objective of this study is to evaluate the efficacy of a specialized exclusive breastfeeding education and support program targeting obese, pregnant, low-income women in Hartford, CT. Specifically, the investigators will evaluate the impact of the intervention on exclusive and partial breastfeeding rates at birth, 1, 3 and 6 months pp. Secondary aims of this study are: a) to characterize postpartum weight loss patterns and blood pressure values of obese women, by study group; and b) to evaluate potential differences in infant morbidity (diarrhea, otitis media and rehospitalization), by study group.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: LC and Electronic Prompt | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: LC and Electronic Prompt; Assigned to Arm(s): 1
B: Arm Label: Treatment as usual; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Behavioral education; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral education intervention | Intervention Type: BEHAVIORAL; Name: Behavioral education intervention; Assigned to Arm(s): Behavioral education
C: Arm Label: Breastfeeding Peer Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Breastfeeding Peer Counseling | Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Breastfeeding Peer Counseling; Assigned to Arm(s): Breastfeeding Peer Counseling
D: Arm Label: visit with grandmother; Type: EXPERIMENTAL; Interventions: Behavioral: counseling sessions | Arm Label: visit without grandmother; Type: EXPERIMENTAL; Interventions: Behavioral: counseling sessions | Arm Label: no visit with grandmother; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: no visit without grandmother; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: counseling sessions; Assigned to Arm(s): visit with grandmother, visit without grandmother

Answer: C